The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders
Open accessAbstract
A wide range of neurodegenerative diseases (NDs), including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and prion diseases, share common mechanisms such as neuronal loss, apoptosis, mitochondrial dysfunction, oxidative stress, and inflammation. Intervention strategies using plant‐derived bioactive compounds have been offered as a form of treatment for these debilitating conditions, as there are currently no remedies to prevent, reverse, or halt the progression of neuronal loss. Rutin, a glycoside of the flavonoid quercetin, is found in many plants and fruits, especially buckwheat, apricots, cherries, grapes, grapefruit, plums, and oranges. Pharmacological studies have reported the beneficial effects of rutin in many disease conditions, and its therapeutic potential in several models of NDs has created considerable excitement. Here, we have summarized the current knowledge on the neuroprotective mechanisms of rutin in various experimental models of NDs. The mechanisms of action reviewed in this article include reduction of proinflammatory cytokines, improved antioxidant enzyme activities, activation of the mitogen‐activated protein kinase cascade, downregulation of mRNA expression of PD‐linked and proapoptotic genes, upregulation of the ion transport and antiapoptotic genes, and restoration of the activities of mitochondrial complex enzymes. Taken together, these findings suggest that rutin may be a promising neuroprotective compound for the treatment of NDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Khodagholi, F., Eftekharzadeh, B., Maghsoudi, N., & Rezaei, P. F. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0284-1 · Cited by 107
RetractedFree radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378 · cited 1×
“ROS play important roles in mediating cellular activities [9, 10]; however, due to their reactivity, high amounts of ROS Hindawi Oxidative Medicine and Cellular Longevity Volume 2018, Article ID 6241017, 17 pages https://doi.”
BackgroundA Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
The Pharmacological Potential of Rutin
Ganeshpurkar, A., & Saluja, A. K. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2016.04.025 · Cited by 1,253
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233
Nature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Mechanism of Oxidative Stress in Neurodegeneration
Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 960
The correlation between active oxygens scavenging and antioxidative effects of flavonoids
Hanasaki, Y., Ogawa, S., & Fukui, S. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90202-x · Cited by 951
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
[Malondialdehyde (MDA) as a lipid peroxidation marker].
Gaweł, S., Wardas, M., Niedworok, E., et al. (2004) · PubMed · Cited by 852
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
Mitochondria, oxidative stress and neurodegeneration
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 787
Beal, M. F. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00780-3 · Cited by 763 · cited 1×
“Increased levels of oxidative stress biomarkers (carbonyls, MDA, and 3-nitrotyrosine) in the blood [59, 60] and changes in the activities of antioxidant enzymes (SOD and CAT) reflect oxidative stress in the brain [61, 62].”
BackgroundDringen, R., Gutterer, J. M., & Hirrlinger, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01597.x · Cited by 760
Barnes, J., Anderson, L. A., & Phillipson, J. D. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775910 · Cited by 749
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 748
Toxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739
Neurodegenerative disease: models, mechanisms, and a new hope
Gitler, A. D., Dhillon, P., & Shorter, J. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030205 · Cited by 739
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718
Abramov, A. Y., Scorziello, A., & Duchen, M. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4468-06.2007 · Cited by 685
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 682
Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
Pennanen, C., Kivipelto, M., Tuomainen, S., Hartikainen, P., Hänninen, T., Laakso, M. P., Hallikainen, M., Vanhanen, M., Nissinen, A., Helkala, E.-L., et al. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00084-8 · Cited by 643
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
Praticò, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.001 · Cited by 606
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597
Manoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Pahwa, R., Factor, S. A., Lyons, K. E., Ondo, W. G., Gronseth, G., Bronte-Stewart, H., Hallett, M., Miyasaki, J., Stevens, J., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215250.82576.87 · Cited by 499
A Unifying Role for Prions in Neurodegenerative Diseases
Prusiner, S. B. (2012) · Science · doi:10.1126/science.1222951 · Cited by 491
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
Trushina, E., & McMurray, C. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.056 · Cited by 439
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 436
The cellular prion protein (PrPC): Its physiological function and role in disease
Westergard, L., Christensen, H. M., & Harris, D. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.011 · Cited by 433
Ageing, neurodegeneration and Parkinson's disease
Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430
Budka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K., et al. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00625.x · Cited by 428
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Rutin: therapeutic potential and recent advances in drug delivery
Sharma, S., Ali, A., Ali, J., Sahni, J. K., & Baboota, S. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.805744 · Cited by 422
Butterfield, D. A., & Kanski, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 419
Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415
Ramsay, R. R., & Singer, T. P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57434-8 · Cited by 412
Huang, W.-Y., Zhang, H.-C., Liu, W.-X., & Li, C.-Y. (2012) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1100137 · Cited by 399
Inflammation and Alzheimer’s disease
Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396
Flavonoids: modulators of brain function?
Spencer, J. P. E. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508965776 · Cited by 384
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 379
Greeson, J. M., Sanford, B., & Monti, D. A. (2001) · Psychopharmacology · doi:10.1007/s002130000625 · Cited by 379
Antioxidant Therapies for Alzheimer's Disease
Feng, Y., & Wang, X. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/472932 · Cited by 379
Goetz, C. G., Poewe, W., Rascol, O., & Sampaio, C. (2005) · Movement Disorders · doi:10.1002/mds.20464 · Cited by 376
Javed, H., Khan, M. M., Ahmad, A., Vaibhav, K., Ahmad, M. E., Khan, A., Ashafaq, M., Islam, F., Siddiqui, M. S., Safhi, M. M., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.046 · Cited by 357
Oxidative stress in neurodegenerative diseases.
Chen, X., Guo, C., & Kong, J. (2012) · PubMed · doi:10.3969/j.issn.1673-5374.2012.05.009 · Cited by 356
Metallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
Akama, K. T., Albanese, C., Pestell, R. G., & Van Eldik, L. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5795 · Cited by 349
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318 · cited 1×
“The underlying mechanisms (Figure 3) proposed for the initiation of oxidative stress in AD include Aβ accumulation [63, 64], hyperphosphorylated tau [65, 66], inflammation [67, 68], mitochondrial dysfunction [64, 69], and metal accumulation [70, 71].”
BackgroundUversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Inactivation of succinate dehydrogenase by 3-nitropropionate.
Coles, C. J., Edmondson, D. E., & Singer, T. P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50574-3 · Cited by 307
Kreft, S., Knapp, M., & Kreft, I. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf990186p · Cited by 307
Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial
Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., & McDonald, S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224350.82719.83 · Cited by 307
Przedborski, S., & Vila, M. (2003) · PubMed · Cited by 286
PRZEDBORSKI, S., & VILA, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07476.x · Cited by 283
Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration
Patten, D. A., Germain, M., Kelly, M. A., & Slack, R. S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100498 · Cited by 278
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Bolisetty, S., & Jaimes, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036306 · Cited by 273
Speech Characteristics of Patients with Parkinson’s Disease: I. Intensity, Pitch, and Duration
Canter, G. J. (1963) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.2803.221 · Cited by 272
A systematic review of prion therapeutics in experimental models
Trevitt, C. R. (2006) · Brain · doi:10.1093/brain/awl150 · Cited by 263
Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish
Richetti, S. K., Blank, M., Capiotti, K. M., Piato, A. L., Bogo, M. R., Vianna, M. R., & Bonan, C. D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.09.027 · Cited by 248
Pang, Z., & Geddes, J. W. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03064.1997 · Cited by 248
Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1006 · Cited by 244
Jiménez-Aliaga, K., Bermejo-Bescós, P., Benedí, J., & Martín-Aragón, S. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.09.023 · Cited by 239
Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease
Torres, L. L., Quaglio, N. B., de Souza, G. T., Garcia, R. T., Dati, L. M. M., Moreira, W. L., de Melo Loureiro, A. P., de souza-Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110284 · Cited by 234
Animal Models of Huntington's Disease
Ramaswamy, S., McBride, J. L., & Kordower, J. H. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.356 · Cited by 234
Xu, P.-X., Wang, S.-W., Yu, X.-L., Su, Y.-J., Wang, T., Zhou, W.-W., Zhang, H., Wang, Y.-J., & Liu, R.-T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.002 · Cited by 232
Treatment of Huntington's Disease
Frank, S. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0244-z · Cited by 230
Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229
Chen, C.-M., Wu, Y.-R., Cheng, M.-L., Liu, J.-L., Lee, Y.-M., Lee, P.-W., Soong, B.-W., & Chiu, D. T.-Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.093 · Cited by 228
Wang, S.-W., Wang, Y.-J., Su, Y.-J., Zhou, W.-W., Yang, S.-G., Zhang, R., Zhao, M., Li, Y.-N., Zhang, Z.-P., Zhan, D.-W., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.03.003 · Cited by 220
The association of affective disorder with Huntington's Disease in a case series and in families
Folstein, S. E., Abbott, M. H., Chase, G. A., Jensen, B. A., & Folstein, M. F. (1983) · Psychological Medicine · doi:10.1017/s0033291700047966 · Cited by 220
Huang, T.-C., Lu, K.-T., Wo, Y.-Y. P., Wu, Y.-J., & Yang, Y.-L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029102 · Cited by 217
Xanthine Oxidase: Isolation, Assays of Activity, and Inhibition
Kostić, D. A., Dimitrijević, D. S., Stojanović, G. S., Palić, I. R., Đorđević, A. S., & Ickovski, J. D. (2015) · Journal of Chemistry · doi:10.1155/2015/294858 · Cited by 202
Nature, distribution and function of plant flavonoids.
Harbörne, J. B. (1986) · PubMed · Cited by 195
Wang, Q., Rowan, M. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0233-04.2004 · Cited by 193
Sheikh, S., Safia, Haque, E., & Mir, S. S. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/563481 · Cited by 189
Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson’s Disease
Moshahid Khan, M., Raza, S. S., Javed, H., Ahmad, A., Khan, A., Islam, F., Safhi, M. M., & Islam, F. (2012) · Neurotoxicity Research · doi:10.1007/s12640-011-9295-2 · Cited by 185
Adverse effects profile of the herbal antidepressant St. John's wort ( Hypericum perforatum L.)
Ernst, E., Rand, J. I., Barnes, J., & Stevinson, C. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050519 · Cited by 183
Parkinson's disease: diagnosis and treatment.
Rao, S., Hofmann, L. A., & Shakil, A. (2006) · PubMed · Cited by 183
The Seminal Role of β-Amyloid in the Pathogenesis of Alzheimer Disease
Joachim, C. L., & Selkoe, D. J. (1992) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199205000-00003 · Cited by 182
Armstrong, M. J., & Miyasaki, J. M. (2012) · Neurology · doi:10.1212/wnl.0b013e318263c443 · Cited by 180
Klepac, N., Relja, M., Klepac, R., Hećimović, S., Babić, T., & Trkulja, V. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0611-y · Cited by 178
Lee, D.-H., Gold, R., & Linker, R. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911783 · Cited by 160
Antioxidants in Huntington's disease
Johri, A., & Beal, M. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.014 · Cited by 159
Neuroprotective Activity of Hypericum perforatum and Its Major Components
Oliveira, A. I., Pinho, C., Sarmento, B., & Dias, A. C. P. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01004 · Cited by 158
Hu, B., Dai, F., Fan, Z., Ma, G., Tang, Q., & Zhang, X. (2015) · Advanced Materials · doi:10.1002/adma.201502227 · Cited by 155
An up-to-date review of rutin and its biological and pharmacological activities
Al-Dhabi, N. A., Arasu, M. V., Park, C. H., et al. (2015) · EXCLI journal · doi:10.17179/excli2014-663 · Cited by 154
Goula, A.-V., Berquist, B. R., Wilson, D. M., Wheeler, V. C., Trottier, Y., & Mérienne, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000749 · Cited by 152
Choi, S., Ju, W., Choi, E., Kim, J., Lea, H.-Z., Carp, R. I., Wísniewski, H. M., & Ys, K. (1998) · Acta Neuropathologica · doi:10.1007/s004010050895 · Cited by 149
Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity
Monte, D. A. D., Sandy, M. S., Ekström, G., & Smith, M. T. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91210-6 · Cited by 145
Kandemır, F. M., Özkaraca, M., Yıldırım, B. A., Hanedan, B., Kirbaş, A., Kilic, K., Şenocak, E. A., & Benzer, F. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1006100 · Cited by 139
Evidence for Oxidative Stress in Experimental Prion Disease
Guentchev, M., Voigtländer, T., Haberler, C., Groschup, M. H., & Budka, H. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0290 · Cited by 138
Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
Cirmi, S., Ferlazzo, N., Lombardo, G. E., Ventura-Spagnolo, E., Gangemi, S., Calapai, G., & Navarra, M. (2016) · Molecules · doi:10.3390/molecules21101312 · Cited by 134
In Vivo Cytotoxicity of the Prion Protein Fragment 106–126
Ettaiche, M., Pichot, R., Vincent, J., & Chabry, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000579200 · Cited by 131
Rutin mediated targeting of signaling machinery in cancer cells
Aras, A., Shatynska‐Mytsyk, I., Gerçek, Y. C., Boztaş, K., Yazgan, M., Fayyaz, S., & Farooqı, A. A. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0124-6 · Cited by 131
Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide
Zhou, L., & Zhu, X. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39323-1 · Cited by 128
Yang, H., Sun, Z., & Chen, S. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-21 · Cited by 124
Moghbelinejad, S., Nassiri‐Asl, M., Farivar, T. N., Abbasi, E., Sheikhi, M., Taghiloo, M., Farsad, F., Samimi, A., & Hajiali, F. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.010 · Cited by 123
Magalingam, K. B., Radhakrishnan, A. K., & Haleagrahara, N. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1375 · Cited by 123
van der Merwe, C., Dyk, H. C. V., Engelbrecht, L., van der Westhuizen, F. H., Kinnear, C. J., Loos, B., & Bardien, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9843-0 · Cited by 123
Self-citationSymptomatic Treatment of Huntington Disease
Adam, O. R., & Jankovic, J. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.01.008 · Cited by 122
Molecular pathology of human prion disease
Wadsworth, J. D. F., & Collinge, J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0735-5 · Cited by 119
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response
Rotblat, B., Southwell, A. L., Ehrnhoefer, D. E., Skotte, N. H., Metzler, M., Franciosi, S., Leprivier, G., Somasekharan, S. P., Barokas, A., Deng, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314421111 · Cited by 118
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3
Pérez, M., Rojo, A. I., Wandosell, F. G., Díaz‐Nido, J., & Ávila, J. (2003) · Biochemical Journal · doi:10.1042/bj20021596 · Cited by 118
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown, D. R. (2005) · PubMed · Cited by 118
The unsolved relationship of brain aging and late-onset Alzheimer disease
Kern, A., & Behl, C. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.016 · Cited by 117
Foster, A. C., Miller, L. P., Oldendorf, W. H., & Schwarcz, R. M. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90239-5 · Cited by 116
Silva, B., Oliveira, P. J., Dias, A. C. P., & Malva, J. O. (2008) · Neurotoxicity Research · doi:10.1007/bf03033510 · Cited by 114
Ihara, Y., CHUDA, M., Kuroda, S., & Hayabara, T. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00192-6 · Cited by 113
Toxin-Induced and Genetic Animal Models of Parkinson's Disease
Hisahara, S., & Shimohama, S. (2010) · Parkinson s Disease · doi:10.4061/2011/951709 · Cited by 112
Gu, Y., Fujioka, H., Mishra, R. S., Li, R., & Singh, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104345200 · Cited by 108
Zhou, S., Yu, G., Chi, L., Zhu, J., Zhang, W., Zhang, Y., & Zhang, L. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.07.007 · Cited by 106
Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress
Yu, X., Li, Y.-N., Zhang, H., Su, Y., Zhou, W., Zhang, Z., Wang, S., Xu, P., Wang, Y., & Liu, R. (2015) · Food & Function · doi:10.1039/c5fo00500k · Cited by 104
Park, S., Sapkota, K., Choi, J., Kim, M.-K., Kim, Y. H., Kim, K. M., Kim, K. J., Oh, H.-N., Kim, S.-J., & Kim, S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1259-5 · Cited by 102
Candore, G., Bulati, M., Caruso, C., Castiglia, L., Colonna‐Romano, G., Bona, D. D., Duro, G., Lio, D., Matranga, D., Pellicanò, M., et al. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0993 · Cited by 101
PrPSc-like prion protein peptide inhibits the function of cellular prion protein
Brown, D. R. (2000) · Biochemical Journal · doi:10.1042/bj3520511 · Cited by 101
Prion Protein and Its Conformational Conversion: A Structural Perspective
Surewicz, W. K., & Apostol, M. I. (2011) · Topics in current chemistry · doi:10.1007/128_2011_165 · Cited by 101
Structure-Function Implications in Alzheimers Disease: Effect of Aβ Oligomers at Central Synapses
Cerpa, W. F., Dinamarca, M. C., & Inestrosa, N. C. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533321 · Cited by 100
Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum
Bordelon, Y. M., Chesselet, M., Nelson, D., Welsh, F. A., & Erecińska, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041629.x · Cited by 100
Ramalingayya, G. V., Cheruku, S. P., Nayak, P. G., Kishore, A., Shenoy, R. R., Rao, C. M., & Nandakumar, K. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s103511 · Cited by 100
Sánchez-Reus, M. I., del Río, M. A. G., Peinado, I. I., Elorza, M., Slowing, K., & Benedí, J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.003 · Cited by 99
Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys
Emerich, D. F., Thanos, C. G., Goddard, M. B., Skinner, S. J. M., Geany, M. S., Bell, W. J., Bintz, B. E., Schneider, P. A., Chu, Y., Babu, R. S., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.014 · Cited by 93
Important Role of Oxidative Stress Biomarkers in Huntington’s Disease
Túnez, I., Sánchez‐López, F., Agüera, E., Fernández‐Bolaños, R., Sánchez, F. M., & Tasset-Cuevas, I. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200605a · Cited by 93
Brusa, L., Orlacchio, A., Moschella, V., Iani, C., Bernardi, G., & Mercuri, N. B. (2008) · Movement Disorders · doi:10.1002/mds.22376 · Cited by 93
Choi, A. Y., Choi, J. H., Lee, J. Y., Yoon, K., Choe, W., Ha, J., Yeo, E., & Kang, I. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.006 · Cited by 92
Neurotrophin p75 Receptor Is Involved in Neuronal Damage by Prion Peptide-(106–126)
Bianca, V. D., Rossi, F., Armato, U., Prà, I. D., Costantini, C., Perini, G., Politi, V., & Valle, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107454200 · Cited by 92
Roberts, R. C., Ahn, A., Swartz, K. J., et al. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1197 · Cited by 88
Clinical correlates of dementia and disability in Huntington's disease
Brandt, J., Strauss, M. E., Larus, J., Jensen, B. A., Folstein, S. E., & Folstein, M. F. (1984) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638408401231 · Cited by 88
Neurotrophins: A Ticket to Ride for BDNF
Thomas, K. L., & Davies, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.03.023 · Cited by 88
Magalingam, K. B., Radhakrishnan, A. K., & Haleagrahara, N. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015613039 · Cited by 88
Suganya, S., & Sumathi, T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9929-4 · Cited by 84
Alteration of free radical metabolism in the brain of mice infected with scrapie agent
Lee, D. W., Sohn, H. O., Lim, H. B., Lee, Y. G., Kim, Y. S., Carp, R. I., & Wísniewski, H. M. (1999) · Free Radical Research · doi:10.1080/10715769900300541 · Cited by 83
Tetrabenazine: Spotlight on Drug Review
Kaur, N., Kumar, P., Jamwal, S., Deshmukh, R. R., & Gauttam, V. K. (2016) · Annals of Neurosciences · doi:10.1159/000449184 · Cited by 81
Quetiapine in the Treatment of Behavioral Disturbances in Patients With Huntington’s Disease
Alpay, M., & Koroshetz, W. J. (2005) · Psychosomatics · doi:10.1176/appi.psy.47.1.70 · Cited by 78
Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes
Wang, Y., Ge, Z. M., Kang, W., Lian, Z., Yao, J. Q., & Zhou, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2090 · Cited by 76
Kim, N.-H., Park, S., Jin, J., Kwon, M.-S., Choi, E., Carp, R. I., & Kim, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02907-3 · Cited by 75
Ribeiro, C. A. J., Grando, V., Dutra‐Filho, C. S., Wannmacher, C. M. D., & Wajner, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04199.x · Cited by 75
Olanzapine for Huntington's Disease: An Open Label Study
Bonelli, R. M., Mahnert, F. A., & Niederwieser, G. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200209000-00007 · Cited by 73
Basu, S., Mohan, M. L., Luo, X., Kundu, B., Kong, Q., & Singh, N. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0317 · Cited by 71
Computational Insights into the Role of Glutathione in Oxidative Stress
Presnell, C. E., Bhatti, G., Numan, L. S., et al. (2013) · Current Neurovascular Research · doi:10.2174/1567202611310020011 · Cited by 70
Janhom, P., & Dharmasaroja, P. (2015) · Journal of Toxicology · doi:10.1155/2015/919058 · Cited by 66
Magalingam, K. B., Radhakrishnan, A. K., Ramdas, P., & Haleagrahara, N. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0400-x · Cited by 66
Roles of Reactive Oxygen Species in Physiology and Pathology
Song, P., & Zou, M. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch30 · Cited by 65
Current Concepts of Neurodegenerative Diseases
Kovács, G. G. (2014) · EMJ Neurology · doi:10.33590/emjneurol/10314777 · Cited by 65
From tau to toxicity: Emerging roles of NMDA receptor in Alzheimer's disease
Chohan, M. O., & Iqbal, K. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10112 · Cited by 64
Kraus, B., Wolff, H., Heilmann, J., & Elstner, E. F. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.020 · Cited by 63
Sharma, S., Narang, J. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/37/375101 · Cited by 63
The flavonoid rutin modulates microglial/macrophage activation to a CD150/CD206 M2 phenotype
da Silva, A. B., Coelho, P. L. C., Amparo, J. A. O., de Almeida, M. M. A., Borges, J. M. P., Souza, C. D. S., Costa, M. D. F. D., Mecha, M., Rodriguez, C. G., da Silva, V. D. A., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.004 · Cited by 61
Neuroprotective effect ofH. perforatum extracts on β-amyloid-induced neurotoxicity
Silva, B. A., Dias, A. C. P., Ferreres, F., Malva, J. O., & Oliveira, C. R. (2004) · Neurotoxicity Research · doi:10.1007/bf03033214 · Cited by 58
Matsuzono, K., Hishikawa, N., Ohta, Y., Yamashita, T., Deguchi, K., Nakano, Y., & Abe, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143084 · Cited by 56
Nandakumar, K., Ramalingayya, G. V., Nampoothiri, M., Nayak, P., Kishore, A., Shenoy, R. R., & Rao, C. M. (2016) · Pharmacognosy Magazine · doi:10.4103/0973-1296.176104 · Cited by 54
Choi, J. Y., Lee, J. M., Lee, D. G., Cho, S., Yoon, Y.-H., Cho, E. J., & Lee, S. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3292 · Cited by 53
Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes
Diomede, L., Sozzani, S., Luini, W., Algeri, M., GIOIA, L. D., Chiesa, R., Lievens, P., Bugiani, O., Forloni, G., Tagliavini, F., et al. (1996) · Biochemical Journal · doi:10.1042/bj3200563 · Cited by 49
The Pathophysiology and Pharmacological Treatment of Huntington Disease
Pidgeon, C., & Rickards, H. E. (2013) · Behavioural Neurology · doi:10.1155/2013/705373 · Cited by 49
Aripiprazole in the treatment of Huntington’s disease: a case series
Ciammola, A., Sassone, J., Mencacci, N. E., et al. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4165 · Cited by 48
McLin, J. P., Thompson, L. M., & Steward, O. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05198.x · Cited by 48
Guan, Z., Söderberg, M. P., Sindelar, P. J., Prusiner, S. B., Kristensson, K., & Dallner, G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010277.x · Cited by 47
MAZZIO, E. A., Close, F. T., & Soliman, K. F. A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12010506 · Cited by 46
Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats
Mohamed, A. R., Soliman, G. Y., Ismail, C. A., & Mannaa, H. F. (2014) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2014.05.005 · Cited by 42
Dupiereux-Fettweis, I., Zorzi, W., Lins, L., Brasseur, R., Colson, P., Heinen, E., & Elmoualij, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.012 · Cited by 40
Al-Enazi, M. M. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.59098 · Cited by 34
The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset
Kendall, A. L. (2000) · Brain · doi:10.1093/brain/123.7.1442 · Cited by 34
Shen, V., Clarence‐Smith, K., Hunter, C., et al. (2013) · Europe PMC (PubMed Central) · doi:10.7916/d81z42c8 · Cited by 29
Na, J., Kim, S., Song, K., et al. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0084-3 · Cited by 28
Cheng, J., Chen, L., Han, S., Qin, L., Chen, N., & Wan, Z. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0616-7 · Cited by 28
Maciej, J., Schäff, C. T., Kanitz, E., Tuchscherer, A., Bruckmaier, R. M., Wolffram, S., & Hammon, H. M. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9361 · Cited by 26
Bagchi, S. P. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90388-x · Cited by 25
Immunotherapy for Prion Diseases: Opportunities and Obstacles
Li, L., Napper, S., & Cashman, N. R. (2010) · Immunotherapy · doi:10.2217/imt.10.3 · Cited by 24
Domínguez-Prieto, M., Velasco, A. L., Vega, L., Tabernero, A., & Medina, J. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160346 · Cited by 24
Stuard, S., Cesarone, M. R., Belcaro, G., Dugall, M., Ledda, A. G., Cacchio, M., Ricci, A., IPPOLITO, E., Renzo, A. D., & Grossi, M. G. (2008) · International Journal of Angiology · doi:10.1055/s-0031-1278299 · Cited by 11
Cited by
Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants
Adamczak, A., Ożarowski, M., & Karpiński, T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010109 · Cited by 478
Therapeutic benefits of rutin and its nanoformulations
Negahdari, R., Bohlouli, S., Sharifi, S., Maleki Dizaj, S., Rahbar Saadat, Y., Khezri, K., Jafari, S., Ahmadian, E., Gorbani Jahandizi, N., & Raeesi, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.6904 · Cited by 296
Metadata
- Authors
- Enogieru, A. B., Haylett, W., Hiss, D. C., Bardien, S., & Ekpo, O. E.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 6241017-6241017
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2811390459
- Cited by
- 476
- References
- 202
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.